Generating AI analysis...
AI Earnings Analysis
| Metric | Current | Previous | YoY Change |
|---|---|---|---|
Revenue | $14.74M | $13.79M | +6.89% |
Cost of Revenue | $21.83M | $11.17M | +95.50% |
Operating Income | $-191.37M | $-96.34M | -98.64% |
Net Income | $-202.49M | $-91.37M | -121.60% |
EPS (Basic) | $-0.50 | $-0.39 | -28.21% |
EPS (Diluted) | $-0.50 | $-0.39 | -28.21% |
R&D Expense | $129.63M | $67.56M | +91.88% |
| Metric | Current | Previous | YoY Change |
|---|---|---|---|
Total Assets | $1.31B | $557.85M | +133.98% |
Current Assets | $584.14M | $343.62M | +70.00% |
Total Liabilities | $371.29M | $156.7M | +136.95% |
Current Liabilities | $141.98M | $73.92M | +92.07% |
Stockholders' Equity | $933.95M | $401.15M | +132.82% |
Cash & Equivalents | $500.45M | $296.33M | +68.89% |
| Metric | Current | Previous | YoY Change |
|---|---|---|---|
Operating Cash Flow | $-131.96M | $-102.3M | -28.99% |
Investing Cash Flow | $-7.27M | $-6.65M | -9.27% |
Financing Cash Flow | $40.53M | $13.9M | +191.62% |
D&A | $19.33M | $7.38M | +162.04% |
| Metric | Current | Previous | YoY Change |
|---|---|---|---|
Operating Margin | -1297.9% | -698.4% | -599.43% |
Net Margin | -1373.3% | — | — |
ROE | -21.7% | — | — |
ROA | -15.5% | — | — |
Current Ratio | $4.114 | — | — |
Debt to Equity | $0.398 | — | — |
Other companies in Biotechnology